You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 69 No. 1, January 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Safe Anesthesia for Peroral Endoscopy

A Subsequent Report

WILLIAM P. KLEITSCH, M.D.

AMA Arch Otolaryngol. 1959;69(1):45-47.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The agents most widely used to produce anesthesia for peroral endoscopy are tetracaine (Pontocaine) and cocaine. They are potent drugs and both are toxic in relatively small doses. When they are instilled into the tracheobronchial tree, the absorption of these agents approaches the speed of an intravenous injection. The combination of toxicity and rapid absorption makes untoward reactions to the anesthetic relatively common, and occasionally a death will result.4

Because the hazard has been recognized, such reactions to cocaine and tetracaine have been studied in detail.1 The conclusions, which correspond to clinical experience, suggest the untoward reactions to these topical anesthetic agents are a result of overdosage rather than drug sensitivity. Rigid dose control is, therefore, required to reduce the hazards of toxicity. This is achieved by reducing the concentration of the solution and limiting the volume administered so that rigid maximum dose control is achieved.

Unfortunately, reducing . . . [Full Text PDF of this Article]


Author Affiliations

Omaha

From the Surgical Service of the Veterans Administration Hospital, Omaha, and of the Creighton University School of Medicine, and the University of Nebraska College of Medicine.


Footnotes

Submitted for publication March 19, 1958.

Read before the 17th Congress of the International Society of Surgery, Mexico, D. F., Oct. 25, 1957.

The tripelennamine, Pyribenzamine, was made available by the Ciba Pharmaceutical Company.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.